Zepp Health Corp-adr (ZEPP) — Institutional Investor Activity (Q2 2026)

ZEPP ranks #7630 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

ZEPP is a disclosed holding of Ken Griffin (Citadel Advisors LLC), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

28 institutions disclose a position in ZEPP, but none treat it as a major bet — even Yiheng Capital Management, L.P., its most concentrated holder, allocates just 0.4% of its own portfolio to it.

FIL Ltd has trimmed its ZEPP position for two straight quarters, cutting it by $13.1M while still holding $3.7M.

ZEPP is down 6.6% today, but institutions show net buying of $1.1M this quarter — a divergence between today's price move and the underlying institutional flow.

ZEPP reported a net loss of $40.1M in its latest fiscal year.

• Not yet profitable — net loss of $40.1M in the latest fiscal year
• Revenue grew 41.8% year over year
• Net income improved year over year, from -$75.7M to -$40.1M
• Operating cash flow was negative, using $25.7M in cash
• Current ratio of 1.02x — below the conventional 1.5x liquidity buffer
• Liabilities run 1.63x equity — within a conventional range